Literature DB >> 11473646

Osteopontin expression in human cyclosporine toxicity.

K L Hudkins1, Q C Le, S Segerer, R J Johnson, C L Davis, C M Giachelli, C E Alpers.   

Abstract

BACKGROUND: Osteopontin is a secreted phosphoprotein that has a number of diverse biological functions, including cell signaling, mediation of cell adhesion, migration, and chemoattraction of monocytes/macrophages. Up-regulation of osteopontin expression by proximal tubular epithelium has been demonstrated in both human and rodent models of renal injury in association with macrophage influx.
METHODS: We studied the expression of osteopontin protein and mRNA in renal donor biopsies (N = 7) and renal transplant biopsies with cyclosporine A toxicity (N = 23) by immunohistochemistry and in situ hybridization. Serial tissue sections were immunostained with a monocyte/macrophage marker, CD68, to demonstrate the pattern of macrophage infiltration.
RESULTS: Strong osteopontin expression was observed in the majority of pretransplant donor biopsies in the absence of any macrophage infiltration. In the biopsies with cyclosporine toxicity, osteopontin expression was widespread and demonstrated moderate immunohistochemical signal intensity that did not correlate with the number of interstitial macrophages present.
CONCLUSIONS: Strong osteopontin protein and mRNA expression by tubular epithelium was observed in pretransplant donor biopsies and in biopsies with cyclosporine toxicity without an inflammatory cell infiltration. Therefore, osteopontin expression alone is insufficient to serve as the principal mediator of intrarenal monocyte/macrophage influx in the transplant setting.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11473646     DOI: 10.1046/j.1523-1755.2001.060002635.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

1.  Protease nexin-1, tPA, and PAI-1 are upregulated in cryoglobulinemic membranoproliferative glomerulonephritis.

Authors:  Sekiko Taneda; Kelly L Hudkins; Anja S Mühlfeld; Jolanta Kowalewska; Jeffrey W Pippin; Stuart J Shankland; Charles E Alpers
Journal:  J Am Soc Nephrol       Date:  2008-01-16       Impact factor: 10.121

2.  Laterality of nephrocalcinosis in kidney stone formers with severe hypocitraturia.

Authors:  Jesse D Le; Brian H Eisner; Timothy Y Tseng; Thomas Chi; Marshall L Stoller
Journal:  BJU Int       Date:  2011-01       Impact factor: 5.588

3.  Inhibition of bone morphogenetic proteins protects against atherosclerosis and vascular calcification.

Authors:  Yucheng Yao; Brian J Bennett; Xuping Wang; Michael E Rosenfeld; Cecilia Giachelli; Aldons J Lusis; Kristina I Boström
Journal:  Circ Res       Date:  2010-06-24       Impact factor: 17.367

4.  Osteopontin expression and microvascular injury in cyclosporine nephrotoxicity.

Authors:  Beom Jin Lim; Pyung Kil Kim; Soon Won Hong; Hyeon Joo Jeong
Journal:  Pediatr Nephrol       Date:  2004-02-03       Impact factor: 3.714

5.  Expression of fibrosis-associated molecules in IgA nephropathy treated with cyclosporine.

Authors:  Beom Jin Lim; Ji Hong Kim; Soon Won Hong; Hyeon Joo Jeong
Journal:  Pediatr Nephrol       Date:  2008-12-09       Impact factor: 3.714

6.  Identification of putative gene based markers of renal toxicity.

Authors:  Rupesh P Amin; Alison E Vickers; Frank Sistare; Karol L Thompson; Richard J Roman; Michael Lawton; Jeffrey Kramer; Hisham K Hamadeh; Jennifer Collins; Sherry Grissom; Lee Bennett; C Jeffrey Tucker; Stacie Wild; Clive Kind; Victor Oreffo; John W Davis; Sandra Curtiss; Jorge M Naciff; Michael Cunningham; Raymond Tennant; James Stevens; Bruce Car; Timothy A Bertram; Cynthia A Afshari
Journal:  Environ Health Perspect       Date:  2004-03       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.